Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit

NCT06334042 is registered in ClinicalTrials.gov with Oguzhan Kahveci as lead sponsor.

NCT NCT06334042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06334042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care Unit
Lead sponsor
Oguzhan Kahveci
Phase
Observational
Overall status
Completed
Start date
February 7, 2024
Completion date
August 14, 2024
Enrollment
309 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chromium deficiency, diabetes mellitus, hypercholesterolemia, hyperlipidemias